Usefulness of N-terminal pro-B-type natriuretic peptide levels in predicting residual myocardial ischemia in patients with ST elevation acute myocardial infarction

Minerva Cardioangiologica

Volumn 55, Issue 2, 2007, Pages 149-155

  Sarullo, F M ^a,e   Gristina, T ^a   Brusca, I ^a   Serio, G ^a   Taormina, A ^a   La Chiusa, S M ^a   Castello, A ^a   Borruso, E ^b   Paterna, S ^c   Di Pasquale, P ^d  

^a Buccheri La Ferla Fatebenefratelli Hospital   (Italy)

^b Division of Cardiology   (Italy)

^c UNIVERSITY OF PALERMO   (Italy)

^d Ospedale GF Ingrassia   (Italy)

^e Buccheri La Ferla Hospital   (Italy)

Author keywords

Myocardial infarction; Natriuretic peptides; Tomography emission computed

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; TETROFOSMIN TC 99M;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HEART SCINTISCANNING; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ST SEGMENT ELEVATION; TREADMILL EXERCISE;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; ECHOCARDIOGRAPHY, STRESS; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; NATRIURETIC PEPTIDE, BRAIN; ODDS RATIO; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 34248592408     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Cowie MR, Struthers AD, Wood DA, Coats AJ, Thompson SG, Poole-Wilson PA et al. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet 1997;350:1349-53.
2. Cowie MR, Mendez GF. BNP and congestive heart failure. Prog Cardiovasc Dis 2002;44:293-321.
3. Maisel A. B-type natriuretic peptide in the diagnosis and management of congestive heart failure. Cardiol Clin 2001;19:557-71.
4. Muders F, Kromer EP, Griese DP, Pfeifer M, Hense HW, Riegger GA et al. Evaluation of plasma natriuretic peptides as markers for left ventricular dysfunction. Am Heart J 1997;134:442-9.
5. Yasue H, Yoshimura M, Sumida H, Kikuta K, Kugiyama K, Jougasaki M et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994;90:195-203.
6. McDonagh TA, Robb SD, Murdoch DR, Morton JJ, Ford I, Morrison CE et al. Biochemical detection of left ventricular dysfunction. Lancet 1998;351:9-13.
7. Boomsma F, van den Meiracker AH. Plasma A- and B-type natriuretic peptides; physiology, methodology and clinical use. Cardiovasc Res 2001;51:442-9.
8. Schrier RW, Abraham WT. Hormones and hemodynamics inherit failure. N Engl J Med 1999;341:577-85.
9. De Lemos JA, Morrow DA, Bentley JH, Omland T, Sabatine MS, McCabe CH et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 2001;345:1014-21.
10. Kikuta K, Yasue H, Yoshimura M, Morita E, Sumida H, Kato H et al. Increased plasma levels of B-type natriuretic peptide in patients with unstable angina. Am Heart J 1996;132:101-7.
11. Morita E, Yasue H, Yoshimura M, Ogawa H, Jougasaki M, Matsumura T et al. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation 1993;88:82-91.
12. Nagaya N, Nishikimi T, Goto Y, Miyao Y, Kobayashi Y, Morii I et al. Plasma brain natriuretic peptide is a biochemical marker for the prediction of progressive ventricular remodelling after acute myocardial infarction. Am Heart J 1998;135:21-8.
13. Richards AM, Nicholls MG, Yandle TG, Frampton C, Espiner EA, Turner JG et al. Plasma N-terminal probrain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation 1998;97:1921-9.
14. Sabatine MS, Morrow DA, de Lemos JA, Gibson CM, Murphy SA, Rifai N et al. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation 2002;105:1760-3.
15. Talwar S, Squire IB, Downie PF, Davies JE, Ng LL. Plasma N-terminal pro-brain natriuretic peptide and cardiotrophin 1 are raised in unstable angina. Heart 2000;84:421-4.
16. Bibbins-Domingo K, Ansari M, Schiller NB, Massie B, Whooley MA. B-type natriuretic peptide and ischemia in patients with stable coronary disease. Data from the Heart and Soul Study. Circulation 2003;108:2987-92.
17. Galvani M, Ottani F, Oltrona L, Ardissino D, Gensini GF, Maggioni AP et al. N-terminal pro-brain natriuretic peptide on admission has prognostic value across the whole spectrum of acute coronary syndromes. Circulation 2004;110:128-34.
18. American Society of Echocardiography Committee on Standards and Subcommittee on Quantitation of Two-Dimensional Echocardiograms. Recommendations for quantitation of left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989;2:358-67.
19. Sarullo FM, Azzarello V, Sarullo A, Cirino G, Di Pasquale P. Relationship between exercise-induced ST segmental depression and myocardial ischemia assessed by technetium-99-m tetrofosmin SPECT imaging in patients with inferior Q wave myocardial infarction. Int J Cardiovasc Imag 2002;18:195-201.
20. Omland T, Persson A, Ng L, O'Brien R, Karlsson T, Herlitz J et al. N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes. Circulation 2002;106:2913-8.
21. Yoshitomi Y, Nishikimi T, Kojima S, Kuramochi M, Takishita S, Kangawa K et al. Plasma natriuretic peptides as indicators of left ventricular remodelling after myocardial infarction. Int J Cardiol 1998;64:153-60.
22. Nagaya N, Goto Y, Nishikimi T, Uematsu M, Miyao Y, Kobayashi Y et al. Sustained elevation of plasma brain natriuretic peptide levels associated with progressive ventricular remodelling after acute myocardial infarction. Clin Sci (Lond) 1999;96:129-36.
23. Crilley JG, Farrer M. Left ventricular remodelling and brain natriuretic peptide after myocardial infarction. Heart 2001;86:638-42.
24. James SK, Lindahl B, Siegbahn A, Stridsberg M, Venge P, Armstrong P et al. N-terminal pro-brain natriuretic peptides and other risk markers for separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease. GUSTO IV Substudy. Circulation 2003;108:275-81.
25. Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett JC Jr. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol 2002;40:976-82.